Corify Care is a biomedical startup whose vision is to improve the prognosis and treatment of patients with cardiac arrhythmias. To this end, its mission is to provide clinicians with the necessary technological tools capable of stratifying patients with cardiac arrhythmias and helping them select and direct the optimal treatment for each patient. The company’s objective is the development and commercial exploitation of noninvasive solutions for the diagnosis of cardiovascular diseases based on the combination of electrocardiographic imaging (ECGI), 3D reconstruction, and artificial intelligence. The first product developed by CORIFY Care is the ACORYS® device, which enables the characterization of cardiac electrophysiological properties during a type of arrhythmia such as atrial fibrillation (AF) and is able to predict the efficacy of current treatments, improving health outcomes for patients in a personalized manner.